Literature DB >> 15925144

Intracisternal administration of chemokines facilitated formalin-induced behavioral responses in the orofacial area of freely moving rats.

D K Ahn1, K R Lee, H J Lee, S K Kim, H S Choi, E J Lim, J S Park.   

Abstract

The present study investigated the effects of intracisternal administration of MCP-1, Rantes or IL-8 on pain transmission in the orofacial area. We also investigated mechanisms of hyperalgesic responses produced by intracisternal administration of IL-8. An orofacial formalin test was employed to assess the effects of chemokines on nociceptive processing. For each animal, the number of behavioral responses and the time spent grooming, rubbing and/or scratching the facial region proximal to the formalin injection site was recorded for nine successive 5-min intervals. Intracisternal administration of MCP-1, Rantes or IL-8 significantly increased formalin-induced scratching behavioral responses in the orofacial area. Intracisternal pretreatment with indomethacin, a non-selective cyclooxygenase inhibitor, did not block IL-8-induced hyperalgesia. Pretreatment with 100 microg propranolol, a non-selective beta-adrenergic receptor antagonist and 50 microg atenolol, a selective beta(1)-adrenergic receptor antagonist, inhibited the number of scratches and the duration of scratching produced by 1 ng of IL-8 injected intracisternally. These results indicate that intracisternal administration of chemokines produce a hyperalgesic response with an orofacial inflammatory pain model and that the IL-8-induced hyperalgesia is mediated by central beta(1)-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925144     DOI: 10.1016/j.brainresbull.2005.03.015

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  5 in total

1.  Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis.

Authors:  Eva Kosek; Reem Altawil; Diana Kadetoff; Anja Finn; Marie Westman; Erwan Le Maître; Magnus Andersson; Mats Jensen-Urstad; Jon Lampa
Journal:  J Neuroimmunol       Date:  2015-02-19       Impact factor: 3.478

2.  Spinal NF-κB and chemokine ligand 5 expression during spinal glial cell activation in a neuropathic pain model.

Authors:  Qin Yin; Qin Fan; Yu Zhao; Ming-Yue Cheng; He Liu; Jing Li; Fei-Fei Lu; Jin-Tai Jia; Wei Cheng; Chang-Dong Yan
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

3.  Involvement of central opiate receptors in modulation of centrally administered oxytocin-induced antinociception.

Authors:  Amir Erfanparast; Esmaeal Tamaddonfard; Sahar Seyedin
Journal:  Iran J Basic Med Sci       Date:  2018-12       Impact factor: 2.699

4.  Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity.

Authors:  Marc-André Dansereau; Élora Midavaine; Valérie Bégin-Lavallée; Mounir Belkouch; Nicolas Beaudet; Jean-Michel Longpré; Stéphane Mélik-Parsadaniantz; Philippe Sarret
Journal:  J Neuroinflammation       Date:  2021-03-23       Impact factor: 8.322

5.  Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotype.

Authors:  Martin Flores Bjurström; Mikael Bodelsson; Agneta Montgomery; Andreas Harsten; Markus Waldén; Shorena Janelidze; Sara Hall; Oskar Hansson; Michael R Irwin; Niklas Mattsson-Carlgren
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.